The antioxidant role of thiocyanate in the pathogenesis of cystic fibrosis and other inflammation-related diseases

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 48, 2009, Pages 20515-20519

  Xu, Yanping ^a   Szép, Szilvia ^a   Lu, Zhe ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Hydrogen peroxide; Hypochlorite; Hypothiocyanite; Lactoperoxidase; Myeloperoxidase

Indexed keywords

CHLORIDE; ENZYME; HYDROGEN PEROXIDE; HYPOCHLORITE; LACTOPEROXIDASE; MYELOPEROXIDASE; THIOCYANATE; THIOCYANIC ACID DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD; BLOOD CELL; CELL PROTECTION; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; LUNG ALVEOLUS CELL; LUNG INJURY; PATHOGENESIS; PLANT; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANTIOXIDANTS; CELL LINE; CELL SURVIVAL; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; INFLAMMATION; LACTOPEROXIDASE; LUNG; PEROXIDASE; THIOCYANATES;

EID: 73949105483     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0911412106     Document Type: Article

References (60)

1. Sturgess J, Imrie J (1982) Quantitative evaluation of the development of tracheal submucosal glands in infants with cystic fibrosis and control infants. Am J Pathol 106:303-311.
2. Ornoy A, et al. (1987) Pathological confirmation of cystic fibrosis in the fetus following prenatal diagnosis. Am J Med Genet 28:935-947.
3. Armstrong DS, et al. (1997) Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 156:1197-1204.
4. Elizur A, Cannon CL, Ferkol TW (2008) Airway inflammation in cystic fibrosis. Chest 133:489-495.
5. Khan TZ, et al. (1995) Early pulmonary inflammation in infants with cystic fibrosis.AmJ Respir Crit Care Med 151:1075-1082.
6. Pilewski JM, FrizzellRA(1999) Role of CFTR in airway disease. Physiol Rev 79:S215-S255.
7. Quinton PM (1983) Chloride impermeability in cystic fibrosis. Nature 301:421-422.
8. Knowles MR, et al. (1983) Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science 221:1067-1070.
9. Widdicombe JH, Welsh MJ, Finkbeiner WE (1985) Cystic fibrosis decreases the apical membrane chloride permeability of monolayers cultured from cells of tracheal epithelium. Proc Natl Acad Sci USA 82:6167-6171.
10. Rommens JM, et al. (1989) Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 245:1059-1065.
11. Kerem B, et al. (1989) Identification of the cystic fibrosis gene: Genetic analysis. Science 245:1073-1080.
12. Riordan JR, et al. (1989) Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245:1066-1073.
13. Knowles MR, et al. (1997) Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects. J Clin Invest 100:2588-2595.
14. Jayaraman S, et al. (2001) Submucosal gland secretions in airways from cystic fibrosis patients have normal [Na+] and pH but elevated viscosity. Proc Natl Acad Sci USA 98:8119-8123.
15. Tirouvanziam R, Khazaal I, Peault B (2002) Primary inflammation in human cystic fibrosis small airways. Am J Physiol Lung Cell Mol Physiol 283:L445-L451.
16. Konstan MW (2008) Ibuprofen therapy for cystic fibrosis lung disease: Revisited. Curr Opin Pulm Med 14:567-573.
17. Brown RK, Wyatt H, Price JF, Kelly FJ (1996) Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur Respir J 9:334-339.
18. Hull J, Vervaart P, Grimwood K, Phelan P (1997) Pulmonary oxidative stress response in young children with cystic fibrosis. Thorax 52:557-560.
19. Jobsis Q, et al. (2000) Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment. Eur Respir J 16:95-100.
20. Van Der Vliet A, Nguyen MN, Shigenaga MK, Eiserich JP, Marelich GP, Cross CE (2000) Myeloperoxidase and protein oxidation in cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 279:L537-L546.
21. The Cystic Fibrosis Foundation (2008) Annual Report.
22. Dawson DC, Smith SS, Mansoura MK (1999) CFTR: Mechanism of anion conduction. Physiol Rev 79:S47-S75.
23. Fragoso MA, et al. (2004) Transcellular thiocyanate transport by human airway epithelia. J Physiol 561:183-194.
24. Wijkstrom-Frei C, et al. (2003) Lactoperoxidase and human airway host defense. Am J Respir Cell Mol Biol 29:206-212.
25. Conner GE, et al. (2007) The lactoperoxidase system links anion transport to host defense in cystic fibrosis. FEBS Lett 581:271-278.
26. Moskwa P, et al. (2007) A novel host defense system of airways is defective in cystic fibrosis. Am J Respir Crit Care Med 175:174-183.
27. El-Chemaly S, et al. (2003) Hydrogen peroxide-scavenging properties of normal human airway secretions. Am J Respir Crit Care Med 167:425-430.
28. Furtmuller PG, et al. (2002) Reaction of lactoperoxidase compound I with halides and thiocyanate. Biochemistry 41:11895-11900.
29. van Dalen CJ, Whitehouse MW, Winterbourn CC, Kettle AJ (1997) Thiocyanate and chloride as competing substrates for myeloperoxidase. Biochem J 327:487-492.
30. Klebanoff SJ (2005) Myeloperoxidase: Friend and foe. J Leukoc Biol 77:598-625.
31. Ashby MT, Carlson AC, Scott MJ (2004) Redox buffering of hypochlorous acid by thiocyanate in physiologic fluids. J Am Chem Soc 126:15976-15977.
32. Haws C, Finkbeiner WE,Widdicombe JH, Wine JJ (1994) CFTR in Calu-3 human airway cells: Channel properties and role in cAMP-activated Cl- conductance. Am J Physiol 266:L502-L512.
33. Wolfson LM, Sumner SS (1993) Antimicrobial activity of the lactoperoxidase system. A review. J Food Prot 56:887-892.
34. Engelhardt JF, et al. (1992) Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet 2:240-248.
35. Jacquot J, et al. (1993) Localization of the cystic fibrosis transmembrane conductance regulator in airway secretory glands. Eur Respir J 6:169-176.
36. Geiszt M, et al. (2003) Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J 17:1502-1504.
37. Shao MX, Nadel JA (2005) Dual oxidase 1-dependent MUC5AC mucin expression in cultured human airway epithelial cells. Proc Natl Acad Sci USA 102:767-772.
38. Cross CE, et al. (1994) Oxidants, antioxidants, and respiratory tract lining fluids. Environ Health Perspect Suppl 102:185-191.
39. Worlitzsch D, Herberth G, Ulrich M, Doring G (1998) Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis. Eur Respir J 11:377-383.
40. Kantar A, et al. (1994) Polymorphonuclear leukocyte-generated oxygen metabolites decrease beat frequency of human respiratory cilia. Lung 172:215-222.
41. Wanner A, Salathe M, O'Riordan TG (1996) Mucociliary clearance in the airways. Am J Respir Crit Care Med 154:1868-1902.
42. Knowles MR, Boucher RC (2002) Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 109:571-577.
43. Löhr M, et al. (1989) Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study. Virchows Arch A Pathol Anat Histopathol 414:179-185.
44. Yung B, et al. (2002) Cystic fibrosis-related diabetes: The role of peripheral insulin resistance and beta-cell dysfunction. Diabet Med 19:221-226.
45. Wiersma JJ, et al. (2008) Diabetes mellitus type 2 is associated with higher levels of myeloperoxidase. Med Sci Monit 14:CR406-CR410.
46. Vogt TM, Selvin S, Widdowson G, Hulley SB (1977) Expired air carbon monoxide and serum thiocyanate as objective measures of cigarette exposure. Am J Public Health 67:545-549.
47. Robertson AS, Burge PS, Cockrill BL (1987)Astudy of serum thiocyanate concentrations in office workers as a means of validating smoking histories and assessing passive exposure to cigarette smoke. Br J Ind Med 44:351-354.
48. Waage H, Silsand T, Urdal P, Langard S (1992) Discrimination of smoking status by thiocyanate and cotinine in serum, and carbon monoxide in expired air. Int J Epidemiol 21:488-493.
49. Taioli E, et al. (2007) Myeloperoxidase G-463A polymorphism and lung cancer: A HuGE genetic susceptibility to environmental carcinogens pooled analysis. Genet Med 9:67-73.
50. Davies MJ, Hawkins CL, Pattison DI, Rees MD (2008) Mammalian heme peroxidases: From molecular mechanisms to health implications. Antioxid Redox Signal 10:1199-1234.
51. Choi DK, et al. (2005) Ablation of the inflammatory enzymemyeloperoxidase mitigates features of Parkinson's disease in mice. J Neurosci 25:6594-6600.
52. Yap YW, Whiteman M, Cheung NS (2007) Chlorinative stress: An under appreciated mediator of neurodegeneration? Cell Signal 19:219-228.
53. Kutter D, et al. (2000) Consequences of total and subtotal myeloperoxidase deficiency: Risk or benefit ? Acta Haematol 104:10-15.
54. Nicholls SJ, Hazen SL (2005) Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 25:1102-1111.
55. Zhang R, et al. (2001) Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286:2136-2142.
56. Sugiyama S, et al. (2004) Hypochlorous acid, amacrophage product, induces endothelial apoptosis and tissue factor expression: Involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler Thromb Vasc Biol 24:1309-1314.
57. Malle E, Furtmuller PG, Sattler W, Obinger C (2007) Myeloperoxidase: A target for new drug development? Br J Pharmacol 152:838-854.
58. Miyazaki J, et al. (1990) Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: Special reference to expression of glucose transporter isoforms. Endocrinology 127:126-132.
59. Degenhardt K, et al. (2002) Bax and Bak independently promote cytochrome C release from mitochondria. J Biol Chem 277:14127-14134.
60. Kettle AJ, Winterbourn CC (1994) Assays for the chlorination activity of myeloperoxidase. Methods in Enzymology 233:502-512.